Skip Navigation

This Article
Right arrow Print PDF (3630K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (25)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Kiledjian, M.
Right arrow Articles by Kadesch, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kiledjian, M.
Right arrow Articles by Kadesch, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1990, Vol. 18, No. 4 957-961
© 1990


MOLECULAR BIOLOGY

Analysis of the human liver/bone/kidney alkaline phosphatase promoter in vivo and in vitro

Megerditch Kiledjian and Tom Kadesch

Department of Human Genetics and The Howard Hughes Medical Institute, University of Pennsylvania School of Medicine Philadelphia, PA 19104–6072, USA

Received September 29, 1989. Revised January 15, 1990. Accepted January 15, 1990.

We have carried out an analysis of the promoter for the human liver/bone/kidney alkaline phosphatase (LBK AP) gene. Using transient transfection assays, the intact promoter directs equal expression of a linked cat gene in Saos-2 cells (osteoblast-derived cells which express very high levels of endogenous LBK AP mRNA) and in HeLa and HepG2 cells (which express low levels of endogenous message). The activity of the transfected promoter apparentty mimics the true in vivo situation since nuclear run-on assays employing Saos-2 and HeLa cells indicate that the endogenous gene is transcribed at approximately the same rate In these two cell types. Transfections of a series of 5' deletion mutants indicate that promoter activity is dependent on multiple motifs, which possibly include several putative Spi binding sites and a TATA box. The LBK AP promoter also directs accurate transcription initiation in HeLa whole cell extracts and in vitro activities of the 5' deletion mutants also suggest that the promoter utilizes multiple motifs.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. Stevens, L. Wang, and R. G. Roeder
Functional Analysis of the OCA-B Promoter
J. Immunol., June 15, 2000; 164(12): 6372 - 6379.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Stevens, J. Ong, U. Kim, L. A. Eckhardt, and R. G. Roeder
Role of OCA-B in 3'-IgH Enhancer Function
J. Immunol., May 15, 2000; 164(10): 5306 - 5312.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C.-Z. He and J. B. E. Burch
The Chicken GATA-6 Locus Contains Multiple Control Regions That Confer Distinct Patterns of Heart Region-specific Expression in Transgenic Mouse Embryos
J. Biol. Chem., November 7, 1997; 272(45): 28550 - 28556.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
C Roman, L Cohn, and K Calame
A dominant negative form of transcription activator mTFE3 created by differential splicing
Science, October 4, 1991; 254(5028): 94 - 97.
[Abstract] [PDF]


Home page
Genes Dev.Home page
D Ruezinsky, H Beckmann, and T Kadesch
Modulation of the IgH enhancer's cell type specificity through a genetic switch.
Genes & Dev., January 1, 1991; 5(1): 29 - 37.
[Abstract] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.